The drivers behind U.S. overdose deaths have changed in the last ten years. Today's problem largely comes from illicitly manufactured synthetic opioid powders, particularly fentanyl, much of which comes from China. Congress and executive agencies will need to look beyond available drug policy tools when considering responses.
Although opioid prescriptions in the U.S. have fallen, opioid overdose deaths remain at historic levels. The continued spread of fentanyl and other illicitly manufactured synthetic opioids suggests the problem could still get worse.
Although overdose deaths from heroin and prescription opioids have declined, deaths involving synthetic opioids are on the rise. Much of the current wave of overdoses is linked to one synthetic opioid: fentanyl.
This paper assesses community perceptions of crime and the police before and after the implementation of an intervention aimed at eliminating overt drug markets through focused deterrence and police-community partnerships emphasizing racial reconciliation.
Bryce Pardo and Beau Kilmer discuss recent trends in U.S. fatal overdoses and drug seizures, factors that have contributed to the rise of synthetic opioids in the U.S., what the future of fentanyl and other synthetic opioids looks like, and traditional and non-traditional policy options for addressing fentanyl problems.
America's fentanyl problem is far deadlier than past crises with other illegal drugs. New ideas, be they public policies, technologies or law enforcement strategies, are desperately needed. Continuing to treat fentanyl just like previous drug epidemics will likely be insufficient and may condemn thousands more to early deaths.
The U.S. overdose crisis worsened dramatically with the arrival of synthetic opioids like fentanyl—now responsible for tens of thousands of deaths annually—and the problem requires innovative new strategies because the epidemic is unlike others that have struck the nation.
The rise of fentanyl and other synthetic opioids is unlike any drug crisis in U.S. history. Limiting policy responses to existing approaches will likely be insufficient and may condemn many people to early deaths.
Spending on cannabis, cocaine, heroin and methamphetamine by Americans reached nearly $150 billion in 2016, with a large proportion of spending coming from the small share of people who use drugs on a daily or near-daily basis.
Americans spent about $150 billion on cannabis, cocaine, heroin, and methamphetamine in 2016—rivaling U.S. spending on alcohol. This number is driven in large part by the small share of people who use drugs on a daily or near-daily basis.
Document submitted on August 19, 2019, as an addendum to testimony before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations on July 25, 2019.
In less than six years, the number of fatal overdoses in the United States that involve synthetic opioids has increased tenfold. Where are synthetic opioids concentrated? And to what extent is the problem spreading?
An overview of testimony by Bryce Pardo presented before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations, on July 25, 2019.
Young adults who live in neighborhoods with more medical marijuana dispensaries use marijuana more frequently than their peers and have more-positive views about the drug. The associations were strongest among young adults who lived near dispensaries that had storefront signs.
Given China's recent decision to ban the unauthorized manufacture of fentanyl, authorities there appear to recognize a growing problem. But China cannot solve the U.S. opioid problem. The United States could do more to reduce demand for opioids as well as drug users' exposure to these powerful drugs.